Mechanistically, CCL18 increases the invasion of NSCLC by binding to the Nir1 in NSCLC, which induces ELMO1-dependent cytoskeletal recombination through RAC1 activation (114). Here, PITPNM3 is linked to non-small cell lung carcinoma.